These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 4312765

  • 1. [Therapy of pulmonary tuberculosis with reserve drugs in the light of our personal observations].
    Kochnowski G.
    Wiad Lek; 1970 Jan 01; 23(1):9-13. PubMed ID: 4312765
    [No Abstract] [Full Text] [Related]

  • 2. [Resistance of tubercle bacilli to cycloserine, viomycin and ethionamide in patients suffering from pulmonary tuberculosis].
    Srednicka-Zajac D, Mysakowska H, Szarewicz-Adamczyk W, Litwin B.
    Ann Univ Mariae Curie Sklodowska Med; 1967 Jan 01; 22():71-8. PubMed ID: 4308440
    [No Abstract] [Full Text] [Related]

  • 3. Drug therapy of resistant cases of pulmonary tuberculosis in Indian patients.
    Mital OP, Agarwala MC, Singh SK.
    Indian J Chest Dis; 1967 Oct 01; 9(4):196-206. PubMed ID: 4323543
    [No Abstract] [Full Text] [Related]

  • 4. [Therapy of pulmonary tuberculosis in its current aspects].
    Gartmann JC.
    Bibl Tuberc; 1965 Oct 01; 20():59-70. PubMed ID: 4291161
    [No Abstract] [Full Text] [Related]

  • 5. Ethionamide, pyrazinamide and cycloserine in drug resistant cases.
    Narang RK, Singh SK.
    Indian J Chest Dis; 1973 Jan 01; 15(1):16-20. PubMed ID: 4695462
    [No Abstract] [Full Text] [Related]

  • 6. The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
    Zierski M.
    Bull Int Union Tuberc; 1968 Dec 01; 41():194-200. PubMed ID: 4303863
    [No Abstract] [Full Text] [Related]

  • 7. [Results of treatment with a combined 3-drug regimen of secondary drugs in chronic cavernous pulmonary tuberculosis. A study under auspices of the International Union against Tuberculosis].
    Zierski M, Zacara A, Woźniak S.
    Gruzlica; 1968 Sep 01; 36(9):809-18. PubMed ID: 4882450
    [No Abstract] [Full Text] [Related]

  • 8. [Triple drug regimen with reserve drugs: ETA, PZA and CS in the treatment of chronic pulmonary tuberculosis].
    Wagner J.
    Gruzlica; 1966 Mar 01; 34(3):249-54. PubMed ID: 5947778
    [No Abstract] [Full Text] [Related]

  • 9. [Pulmonary tuberculosis resistant to streptomycin and isoniazid and treated wtih a combination of ethionamide, pyrazinamide, and cycloserine (200 cases)].
    Bartal M, Nejjar A, Laraki A.
    Tunis Med; 1973 Jul 01; 51(4):237-43. PubMed ID: 4209977
    [No Abstract] [Full Text] [Related]

  • 10. [Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital].
    Sirota DS, Man'kovetskiĭ EF, Koĭfman SG, Vatsyk MZ.
    Probl Tuberk; 1974 Jul 01; (10):17-9. PubMed ID: 4370967
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of pulmonary tuberculosis with ethionamide, cycloserine and pyrazinamide in Hong Kong.
    Horsfall PA.
    Bull Int Union Tuberc; 1972 Aug 01; 47 Suppl 2():91-100. PubMed ID: 4662516
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of chronic destructive forms of pulmonary tuberculosis with drugs of the second series in different combinations].
    Mamolat AS, Bialik IB.
    Probl Tuberk; 1969 Aug 01; 47(6):23-8. PubMed ID: 4311969
    [No Abstract] [Full Text] [Related]

  • 13. [Preparations of the 2d series in the complex treatment of middle-aged and elderly patients with pulmonary tuberculosis].
    Iaschenko BP.
    Probl Tuberk; 1967 Aug 01; 45(9):21-6. PubMed ID: 4303748
    [No Abstract] [Full Text] [Related]

  • 14. [Kanamycin and florimycin in the clinical course of pulmonary tuberculosis].
    Bialik IB.
    Antibiotiki; 1971 Feb 01; 16(2):184-8. PubMed ID: 4326728
    [No Abstract] [Full Text] [Related]

  • 15. Clinical efficiency of cycloserine in association with other tuberculostatics.
    Anastasatu C, Ulpian C, Weiss P.
    Scand J Respir Dis Suppl; 1970 Feb 01; 71():152-4. PubMed ID: 5271976
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of chronic polyresistant pulmonary tuberculosis using ethionamide, pyrazinamide and cycloserine].
    Sighart H, Opl G.
    Prax Pneumol; 1968 Nov 01; 22(11):692-8. PubMed ID: 5714048
    [No Abstract] [Full Text] [Related]

  • 17. The results of treatment in patients with cultures resistant to streptomycin, isoniazid and PAS: a five-year follow-up.
    Tousek J, Jancik E, Zelenka M, Jancikova-Máková M.
    Tubercle; 1967 Mar 01; 48(1):27-31. PubMed ID: 4291925
    [No Abstract] [Full Text] [Related]

  • 18. [Current questions in the treatment of patients with chronic destructive pulmonary tuberculosis].
    Mamolat AS, Bialik IB, Khutorskaia VD.
    Klin Med (Mosk); 1976 Dec 01; 54(12):72-8. PubMed ID: 189127
    [No Abstract] [Full Text] [Related]

  • 19. [Late results of treatment of chronic, cavernous pulmonary tuberculosis with reserve drugs].
    Zierski M, Zachara A.
    Gruzlica; 1968 Dec 01; 37(1):31-8. PubMed ID: 5720035
    [No Abstract] [Full Text] [Related]

  • 20. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES, Komarova AA.
    Sov Med; 1967 Jun 01; 30(6):107-10. PubMed ID: 5611339
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.